<DOC>
	<DOCNO>NCT00461591</DOCNO>
	<brief_summary>The purpose study evaluate recurrence rate noninvasive bladder cancer 2 year patient tumor histology Ta , G1-G2 randomize receive TUR-BT plus EOquin® versus randomize receive TUR-BT plus placebo .</brief_summary>
	<brief_title>Trial Single-Dose Intravesical EOquin® Surgical Adjuvant Instilled Early Postoperative Period Patients Undergoing TUR-BT</brief_title>
	<detailed_description>This multicenter , randomize , placebo-controlled , double-blind , study . Following TUR-BT , eligible patient randomize receive either intravesical EOquin® match placebo instill within 6 hour surgery . Patients see postoperative follow-up exam 21±10 day TUR . At time , pathology report review . If histology patient 's tumor Ta , G1-G2 ( low grade [ WHO/ISUP classification ] ) , patient receive treatment observe cystoscopically every three month year two tumor recurrence progression . If histology patient 's tumor Ta , G1-G2 ( low grade [ WHO/ISUP classification ] ) , patient receive treatment accordance current treatment guideline , follow patient follow cystoscopically every three month year two tumor recurrence progression .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Apaziquone</mesh_term>
	<criteria>( All question must answer YES ) Has patient give write informed consent ? Is patient least 18 year old ? Does patient transitional cell carcinoma bladder clinically apparent stage Ta , grade G1G2 ? If patient female childbearing potential , use acceptable/effective method contraception ? If patient female childbearing potential , negative serum pregnancy test within past 14 day ? Is patient willing able abide protocol ? ( All question must answer NO ) Does patient 4 bladder tumor ? Does single bladder tumor exceed 3.5 cm diameter ? Does patient single , primary ( previous diagnosis TCC ) bladder tumor &lt; 0.5 cm ? Has patient ever receive EOquin ( r ) ? Does patient , patient ever , bladder tumor know stage Ta grade G1 G2 ( low grade [ WHO/ISUP classification ] ) ? Does patient , patient ever bladder tumor histology transitional cell carcinoma ? Does patient , patient ever , CIS ? Does patient active urinary tract infection ? Does patient bleed disorder screen platelet count &lt; 100 x 10^9/L ? Does patient unstable medical condition would make unsafe him/her undergo TURBT general spinal anesthesia ? Does patient screen hemoglobin &lt; 10 mg/dL , screen absolute neutrophil count &lt; 1.5 x 10^9/L screen creatinine &gt; 2 mg/dL ? Does patient know immunodeficiency disorder ? Has patient receive investigational treatment within past 30 day ? Is patient breast feeding ? Does patient history interstitial cystitis ? Does patient history allergy red color food dye ? Has patient transitional cell carcinoma bladder within past 4 month ?</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Noninvasive Bladder Cancer</keyword>
</DOC>